Pediatric Oncology

Cancer Predisposition

Questions discussed in this category

What adjustments, if any, do you make to chemotherapy regimens for patients with chromosomal breakage disorders who develop malignancy?

Are there particular drugs you avoid or dose-adjustments that are recommended?

1 Answer available

How would you approach breast cancer screening in an adolescent patient with a CDH1 mutation?

0 Answers available

How would you treat a young patient with classical intermediate-risk Hodgkin lymphoma who has an underlying DNA repair-deficiency disorder, such as congenital mismatch repair disorder or ataxia telangiectasia?

How does your treatment approach vary depending on the underlying predisposition?

1 Answer available

Papers discussed in this category

Cancers (Basel), 2022 Apr 14

Consensus Recommendations for the Clinical Management of Hematological Malignancies in Patients with DNA Double Stranded Break Disorders.

Related Topics in Pediatric Oncology